Mumbai:Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

Asian markets opened higher amid positive global cues. Last checked, Japan's Nikkei 225 index was trading 0.42 per cent ...

One 97 Communications: Antfin in its clean out trade, to sell 5.84% stake at Rs 1020 apiece. The block deal size is Rs 3,800 ...

Stocks including Paytm, Aditya Infotech, Bosch, Laxmi India Finance, Aurobindo Pharma, DLF, Bharti Airtel, Siemens Energy and ...

Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.

Aurobindo Pharma Ltd. reported a 10.3 per cent year-on-year (YoY) decline in consolidated net profit to Rs 824.2 crore in Q1 ...

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...